Duration of adjuvant treatment for patients with stage III colon cancer

This publication has 8 references indexed in Scilit:

• Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials
  The Lancet Oncology, 2020
• A new prognostic and predictive tool for shared decision making in stage III colon cancer
  European Journal of Cancer, 2020
• Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
  Annals of Oncology, 2020
• Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer
  Journal of Clinical Oncology, 2020
• Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR)
  Journal of Clinical Oncology, 2020
• Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
  New England Journal of Medicine, 2018
• Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology)
  British Journal of Cancer, 2017
• Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
  Science Translational Medicine, 2016